Phillip Perkins, MD
General Practice · Wilson, NCNPI 1437108123
Payments from drug & device makers
Across 18 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$91
- Smith+Nephew$53
- Boehringer Ingelheim$50
- AbbVie$42
- Lilly USA, LLC$29
- Corium, LLC$17
- plus $46 from 3 others
What the payments were for
- Food & beverage$327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $91 |
| Smith+Nephew | 2 | $53 |
| Boehringer Ingelheim | 2 | $50 |
| AbbVie | 2 | $42 |
| Lilly USA, LLC | 2 | $29 |
| Corium, LLC | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
How this compares
$327 in reported general payments places this provider in the 60th percentile of 2,924 general practice providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $13,851 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $498 |
| Levothyroxine Sodium | 79 | $496 |
| Morphine Sulfate | 19 | $354 |
| Lorazepam | 32 | $349 |
| Cefdinir | 20 | $303 |
| Donepezil Hcl | 59 | $290 |
| CefuroximeCefuroxime Axetil | 31 | $287 |
| Memantine Hcl | 17 | $278 |
| Haloperidol Lactate | 17 | $260 |
| Memantine Hcl ErMemantine Hcl | 16 | $259 |
| Doxycycline Hyclate | 24 | $246 |
| Atorvastatin Calcium | 38 | $231 |
| Prochlorperazine Maleate | 15 | $222 |
| Quetiapine Fumarate | 63 | $204 |
Paid to pharmacies, not to this prescriber.
Other general practice in Wilson
- Matthew MillerCharlotte$937K
- James BarberDurham$768K
- Robert LoweCharlotte$615K
- Howard JamesSanford$483K
- Clifton CameronFayetteville$404K
- Michael HarrisonRaleigh$249K
- Ronnie DavidsonMooresville$151K
- Leo HaydtHolly Springs$119K
- Andrew KellyGreensboro$115K
- Mark HymanGreensboro$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.